שמור ב:
| מחבר ראשי: | |
|---|---|
| פורמט: | Recurso digital |
| שפה: | |
| יצא לאור: |
Zenodo
2025
|
| גישה מקוונת: | https://doi.org/10.5281/zenodo.17444165 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
תוכן הענינים:
- <p><span>Nicotinamide Mononucleotide (NMN) serves as a significant precursor to nicotinamide adenine dinucleotide (NAD⁺), and it is gaining attention for its ability to enhance cellular metabolism and promote healthy aging. NMN has significant potential as a functional food ingredient, </span>however, incorporating it into nutritional strategies presents certain challenges. NMN naturally occurs in small amounts in foods such as broccoli, avocado, and edamame.<span> </span>The quantities of NMN obtained from dietary sources are insufficient to achieve its therapeutic benefits, making supplementation necessary. However, NMN exhibits chemical instability during processing and storage, and its regulatory approval varies across regions, leading to inconsistencies in its application in functional foods and dietary supplements.<span> Research for delivery and bioavailability enhancements, including encapsulation and/or sustained release models, is ongoing. Devoted intervention studies continue to exist to demonstrate the health impacts of NMN. Given the continued progression of interest, NMN will be an attractive option for products focused on health, longevity and metabolic health. This potential is a key development within the nutraceutical sector.</span></p>